← All stocks

Arteris, Inc.

AIP Mostly scheduled
CIK 0001667011 #2438 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$119.36M
$105.88M on a plan · $9.18M straight out of an exercise
Sold at will
$4.30M
37 of 230 sales
Net
−$119.36M
−$4.30M against sales at will

By person

13 insiders · 231 transactions
765×

K. Charles Janac holds 765 times base salary in stock. $365.17M of shares against $477.00K in salary for 2025.

Salary from the company's own proxy. The shares are what K. Charles Janac last reported holding, valued at $21.75, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
JANAC K CHARLES
President and CEO
$41.68M (63) scheduled
−$41.68M
16,789,542
34.16%
$365.17M
−11.6%
Bayview Legacy, LLC entity
10% owner
$39.85M (40) scheduled
−$39.85M
16,558,142
33.69%
$360.14M
−9.1%
RAZA SAIYED ATIQ
Director
$16.59M (20) scheduled
−$16.59M
4,703
0.0096%
$102.29K
−99.5%
Hawkins Nicholas B.
VP and Chief Financial Officer
$8.41M (24) scheduled
−$8.41M
95,666
0.1946%
$2.08M
−58.7%
Moll Laurent R
Chief Operating Officer
$4.62M (31) scheduled
−$4.62M
212,478
0.4323%
$4.62M
−57.7%
Viana Antonio J
Director
$4.30M (11) scheduled
−$4.30M
69,324
0.1410%
$1.51M
−69.0%
Alpern Paul L
VP and General Counsel
$2.09M (37) scheduled
−$2.09M
70,733
0.1439%
$1.54M
−4.3%
Cantwell Wayne C
Director
$1.43M (1)
−$1.43M
465,728
0.9475%
$10.13M
−1.3%
Chitkara Raman
Director
$375.81K (3) scheduled
−$375.81K
147,570
0.3002%
$3.21M
+7.7%
Sinha Saurabh
Chief Financial Officer
142,835
0.2906%
$3.11M
Geday Isabelle F
Director
121,213
0.2466%
$2.64M
−11.4%
Munce Claudia F.
Director
106,764
0.2172%
$2.32M
+33.4%
Kunkel Joachim
Director
74,695
0.1520%
$1.62M
+86.3%
Insider
Date
Role
Action
Shares
Price
Amount
Alpern Paul L
1 Sep 2026
VP and General Counsel
Sold after exercise
4,000
$20.77
$83.06K
Hawkins Nicholas B.
13 Aug 2026
VP and Chief Financial Officer
Sold after exercise
10,431
$28.26
$294.83K
Alpern Paul L
3 Aug 2026
VP and General Counsel
Sold after exercise
3,400
$30.20
$102.68K
Alpern Paul L
3 Aug 2026
VP and General Counsel
Sold after exercise
600
$29.11
$17.47K
Alpern Paul L
1 Jul 2026
VP and General Counsel
Sold after exercise
900
$47.11
$42.40K
Alpern Paul L
1 Jul 2026
VP and General Counsel
Sold after exercise
2,521
$46.23
$116.54K
Alpern Paul L
1 Jul 2026
VP and General Counsel
Sold after exercise
983
$45.08
$44.31K
Alpern Paul L
1 Jul 2026
VP and General Counsel
Sold after exercise
2,096
$44.02
$92.26K
Alpern Paul L
1 Jun 2026
VP and General Counsel
Sold after exercise
998
$36.39
$36.32K
Alpern Paul L
1 Jun 2026
VP and General Counsel
Sold after exercise
11,504
$35.98
$413.97K
Hawkins Nicholas B.
15 May 2026
VP and Chief Financial Officer
Sold after exercise
3,191
$34.59
$110.36K
Hawkins Nicholas B.
15 May 2026
VP and Chief Financial Officer
Sold after exercise
164,916
$33.51
$5.53M
Hawkins Nicholas B.
15 May 2026
VP and Chief Financial Officer
Sold after exercise
52,928
$32.97
$1.75M
Alpern Paul L
2 Feb 2026
VP and General Counsel
Sold after exercise
5,000
$15.48
$77.38K
Alpern Paul L
5 Jan 2026
VP and General Counsel
Sold after exercise
2,500
$16.00
$40.00K
Alpern Paul L
2 Jan 2026
VP and General Counsel
Sold after exercise
5,000
$15.45
$77.25K
Alpern Paul L
2 Jan 2026
VP and General Counsel
Sold after exercise
794
$15.45
$12.26K
Alpern Paul L
2 Jan 2026
VP and General Counsel
Sold after exercise
1,159
$15.45
$17.90K
Alpern Paul L
2 Jan 2026
VP and General Counsel
Sold after exercise
1,356
$15.45
$20.95K
Alpern Paul L
4 Dec 2025
VP and General Counsel
Sold after exercise
7,500
$16.09
$120.64K
Alpern Paul L
1 Dec 2025
VP and General Counsel
Sold after exercise
5,000
$14.30
$71.49K
Alpern Paul L
3 Nov 2025
VP and General Counsel
Sold after exercise
5,000
$13.16
$65.81K
Alpern Paul L
1 Oct 2025
VP and General Counsel
Sold after exercise
5,000
$10.31
$51.54K

What was left out

Form 4 filings counted 123
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 170
Sales straight out of an exercise 23
Sales at will 37
Transactions with no price 0
Shares from compensation/vesting 978,777
History held since 29 Oct 2021